Maintenance therapy of intermittent high-dose methotrexate in acute childhood leukemia--4-year survivals
Fujimoto, T.; Sasaki, K.; Goya, N.
Nihon Ketsueki Gakkai Zasshi Journal of Japan Haematological Society 41(4): 810-812
1978
ISSN/ISBN: 0001-5806 PMID: 281084 Document Number: 124544
Document emailed within 1 workday
Related Documents
Miyauchi, Y.; Mii, Y.; Morishita, T.; Miura, S.; Honoki, K.; Aoki, M.; Kido, A.; Tamai, S.; Hino, M.; Nomura, Y.; Nakanishi, E. 1996: A device for rapid elevation of plasma methotrexate (MTX) concentration and its maintenance in high-dose MTX therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(5): 595-599Ellison, R.R.; Hoogstraten, B.; Holland, J.F.; Levy, R.N.; Lee, S.L.; Silver, R.T.; Leone, L.A.; Cooper, T.; Oberfield, R.A.; Ten Pas, A.; Blom, J.; Jacquillat, C.; Haurani, F. 1972: Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia Cancer ChemoTherapy Reports 56(4): 535-542
Wang, J.J.; Freeman, A.I.; Sinks, L.F. 1976: Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate Cancer Research 36(4): 1441-1444
Komatsu, K. 1990: Effect of high-dose methotrexate on cerebral metabolic rate of glucose in rats and children with acute lymphoblastic leukemia No to Hattatsu 22(5): 477-482
Sasazaki, Y.; Asami, K.; Utsumi, J. 1992: Transient subacute encephalopathy induced by high-dose methotrexate treatment in children with acute lymphoblastic leukemia and malignant lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(11): 1851-1857
Iqbal, M.P.; Malik, I.; Mehboobali, N. 1992: Appearance of a methotrexate binding plasma protein during high dose methotrexate therapy JPMA. Journal of the Pakistan Medical Association 42(8): 193-196
Pratt, C.B.; Roberts, D.; Shanks, E.C.; Warmath, E.L. 1974: Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors Cancer Research 34(12): 3326-3331
Ohshima, A.; Yoshida, K.; Sato, T.; Miyazaki, S.; Yanagisawa, M.; Nakayama, Y.; Takahashi, T.; Mamiya, S.; Fukusima, Y.; Miura, A.B. 1987: Intermediate- and high-dose cytosine arabinoside therapy in acute refractory leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(1): 192-195
Arlin, Z.A.; Feldman, E.J.; Finger, L.R.; Ahmed, T.; Mittelman, A.; Cook, P.; Puccio, C.; Baskind, P.; Arnold, P.; Razis, E.D. 1991: Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia Leukemia 5(8): 712-714
Dłuzniewska, A.; Balwierz, W.; Balcerska, A.; Chybicka, A.; Kamieńska, E.; Karolczyk, G.; Karpińska-Derda, I.; Krawczuk-Rybak, M.; Kowalczyk, J.R.; Lewandowska, D.; Maciejka-Kapuścińska, L.; Kołtano, S.; Malinowska, I.; Matysiak, Mł.; Mikołajczyk, M.; Mizia-Malarz, A.; Muszyńska-Rosłan, K.; Niedźwiedzki, M.; Pohorecka, J.; Sikorska-Fic, B.; Sobol, G.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Urasiński, T.; Wachowiak, J.; Wieczorek, M.; Wójcik, B.; Wysocki, M. 2010: Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia Przeglad Lekarski 67(6): 366-370
Muchi, H.; Ijima, H.; Karube, T. 1985: The treatment of childhood acute lymphoblastic leukemia based on the pharmacokinetics of methotrexate in serum and cerebrospinal fluid Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 48(6): 1397-1408
Howell, S.B.; Carmody, J. 1977: Changes in glomerular filtration rate associated with high-dose methotrexate therapy in adults Cancer Treatment Reports 61(7): 1389-1391
Rella, W.; Leber, H.; Kotz, R. 1977: Cellular immunity during and after high-dose methotrexate therapy in patients with osteosarcoma Wiener Klinische Wochenschrift 89(22): 751-755
Musso, M.; Porretto, F.; Crescimanno, A.; Bondì, F.; Polizzi, V.; Scalone, R.; Tolomeo, M.; Mariani, G. 1997: Low-dose long-term oral idarubicin in maintenance treatment of elderly acute myeloid leukemia Haematologica 82(5 Suppl): 4-8
Kataoka, A.; Imai, H.; Inayoshi, S.; Tsuda, T. 1993: Intermittent high-dose vitamin C therapy in patients with HTLV-I-associated myelopathy Rinsho Shinkeigaku 33(3): 282-288
Hung, I.J.; Yang, C.P. 1989: Evaluation of methotrexate containing chemotherapeutic regimens in the treatment of childhood undifferentiated non-Hodgkin's lymphoma and B cell acute lymphoblastic leukemia Journal of the Formosan Medical Association 88(10): 1016-1022
Sanz, M.A.; Martínez, J.; Borrego, D.; Martín-Aragonés, G.; Lorenzo, I.; Sanz, G.; Sayas, M.J.; Jarque, I.; Pastor, E.; Rafecas, J. 1987: High-dose cytosine arabinoside and mitoxantrone in high-risk acute nonlymphoblastic leukemia Seminars in Oncology 14(2 Suppl 1): 18-20
Isacoff, W.H.; Eilber, F.; Tabbarah, H.; Klein, P.; Dollinger, M.; Lemkin, S.; Sheehy, P.; Cone, L.; Rosenbloom, B.; Sieger, L.; Block, J.B. 1978: Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue Cancer Treatment Reports 62(9): 1295-1304
Monsereenusorn, C.; Rujkijyanont, P.; Srimanan, W.; Traivaree, C. 2015: Isolated Ocular Relapse in Childhood Acute Lymphoblastic Leukemia during Second Interim Maintenance Phase of Chemotherapy: Case Report Journal of the Medical Association of Thailand 98(11): 1150-1153
Liu, H.C.; Liang, D.C.; Chen, S.H.; Lo, C.Y.; Tseng, K.P.; Kuo, T.B.; Chen, H.J.; Wang, S.J. 1996: Intelligence quotient in childhood acute lymphoblastic leukemia after prophylactic treatment in central nervous system with 18 Gy cranial irradiation and intrathecal methotrexate Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 37(2): 107-110